As the House Energy and Commerce Committee prepares to consider a legislative provision (H.R. 3561) that would reduce payments for drug administration services furnished in off-campus provider-based departments, the AHA and other national hospital groups reiterated to committee leaders their opposition to the proposal and to site-neutral policies in general, which fail to account for the fundamental differences between hospital outpatient departments (HOPDs) and other ambulatory care sites. 

“It is important to note that HOPDs treat patients who are sicker and have more chronic conditions than those treated in physician offices or ambulatory surgical centers, as they are better equipped to handle complications and emergencies,” the letter notes. The committee is scheduled to consider H.R. 3561 tomorrow.

AHA also released a fact sheet highlighting three site-neutral proposals being considered by the committee and their estimated impact on Medicare reimbursement to hospitals and health systems; the estimates should not be combined because the legislative proposals contain some overlap. 

Related News Articles

Headline
The AHA July 11 released its quarterly Health Care Plan Accountability Update, a roundup of news, letters, statements and other resources covering private…
Headline
The AHA submitted a statement July 11 for a Senate Special Committee on Aging hearing on health care transparency and lowering health care costs. The AHA…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The Healthcare Equality Network July 3 sent a letter to the Centers for Medicare & Medicaid Services, expressing concerns about claims denials by…
Headline
The Department of Health and Human Services’ Office of Inspector General last week announced its intent to investigate Medicare Advantage Organizations’ prior…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…